Full-Time
SAP Basis Engineer
Posted on 9/10/2026
Alphatec Spine
1,001-5,000 employees
Develops and markets spinal surgery solutions
Compensation Overview
$120k - $130k/yr
Carlsbad, CA, USA
In Person
Bachelor's
 IT Operations (1) |
|---|
Get referred to Alphatec Spine
See people who can refer or advise you
- A bachelor's degree or equivalent in Information Systems, Computer Science, or Engineering.
- 5–7 years of hands-on experience as an SAP Basis and Security Administrator.
- Experience with at least two SAP implementations, upgrades, conversions, or migrations, including at least one implementation in the RISE with SAP context coordinating with SAP ECS.
- Strong oral and written communication skills.
- Ability to organize and prioritize workflow to meet established deadlines.
- Ability to work within a cross-functional team.
- Proficiency in Microsoft Word, Excel, PowerPoint, and internet applications.
- Ability to perform multiple tasks in a fast-paced, team-focused environment.
- For roles based in the United States that require access to hospital facilities, eligibility to obtain and maintain credentials at all required hospitals, including meeting applicable physical or vaccination requirements, including the COVID-19 vaccine where applicable.
- Interface directly with Infrastructure, Networking, and Technical teams to understand requirements and support business functions and system capabilities.
- Manage the complex SAP landscape end to end, including SAP system management, maintenance, operation, and SAP integration support.
- Design, build, test, deploy, and manage SAP systems, including S/4HANA, BTP solutions and services, CPI, Datasphere, and other SAP solutions.
- Implement the technical approach for SAP and non-SAP systems integrating with SAP solutions and manage SAP and third-party dependencies related to the SAP environment.
- Design, implement, and maintain SAP security architecture, including roles, authorizations, and segregation-of-duties controls across the SAP landscape.
- Plan and manage SAP system maintenance schedules in coordination with internal and external stakeholders, including SAP ECS and RISE.
- Apply SAP best practices.
- Perform performance tuning, configuration, troubleshooting, and root-cause analysis related to HANA databases, S/4HANA, and other SAP SaaS solutions.
- Implement, upgrade, and support current SAP system versions.
- Oversee BTP landscape setup and maintenance, including single sign-on.
- Own and drive ATEC's SAP infrastructure to support future needs and scalability while applying industry-leading best practices.
- Drive design and engineering efficiency and optimize the development process for continuous product delivery.
- Implement solutions that streamline processes, reduce redundancy, and improve the internal customer experience.
- Document system architecture, security models, and operational procedures for a growing, well-governed SAP environment.
- Provide on-call support during weekdays and weekends according to the schedule.
Alphatec Spine develops and sells implants, instruments, and integrated technologies for spine surgery, including devices used in fusion procedures and related navigation or imaging systems gained through acquisitions like SafeOp Surgical. During surgery, surgeons use these implants and instruments, often with imaging or navigation tools to plan and guide the procedure, while the implants support fusion and healing. It differentiates itself with a broad product portfolio and enhanced technology through strategic acquisitions, giving it capabilities in navigation and advanced spine solutions beyond a narrow line of implants. Its goal is to improve spinal surgery outcomes and expand access to effective spine-care solutions.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Carlsbad, California
Founded
1990
Get referred to Alphatec Spine
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue reached $214 million, up 15%, with surgical revenue up 17%.
- Adjusted EBITDA hit $36 million, and Alphatec raised 2026 guidance to $140 million.
- Management expects at least $20 million free cash flow and continued full-year growth.
What critics are saying
- EOS revenue missed Q1 2026 expectations, triggering a 32% share drop May 5.
- Kirby McInerney and Ademi investigations target Alphatec's May 2026 disclosures.
- Persistent EOS installation failures would destroy surgeon trust and compress valuation through 2027.
What makes Alphatec Spine unique
- EOS imaging, navigation, and implants bundle spine surgery workflows into one platform.
- Q2 2026 net new surgeon users rose 24%, showing sticky clinical adoption.
- The 2031 bank facility supports scaling without near-term refinancing distractions.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Paid Vacation
Paid Sick Leave
Paid Holidays
Disability Insurance
Stock Options
Growth & Insights and Company News
6 month growth
↑ 4%1 year growth
↑ 4%2 year growth
↑ 4%Alphatec Holdings reported strong Q2 2026 results with total revenue of $214 million, up 15% year-over-year, and surgical revenue of $196 million, up 17%. The medical device company saw adjusted EBITDA rise 53% to $36 million, with margins expanding 420 basis points to 17%. The company added 24% more net new surgeons and posted 20% case volume growth. Gross margin improved 260 basis points to 72.5%, driven by better inventory efficiency and favourable product mix. Alphatec generated positive free cash flow of approximately $1 million in Q2 and raised full-year adjusted EBITDA guidance to $140 million from $134 million previously. However, revenue per case declined 2.7% due to case mix shifts and international growth. The company now expects full-year revenue per case to decline in the low single digits, citing slower biologics attachment improvement.
Alphatec, a spine surgery technology company, reported revenue of $764.2 million in FY 2025, up 25% year-over-year, but posted a net loss of $143.4 million. The company's debt-to-equity ratio stands at approximately 17.2x, whilst its current ratio is 2.1x. Stock-based compensation represented roughly 163% of operating cash flow. Inspire Medical Systems specialises in neurostimulation therapy for obstructive sleep apnea patients who cannot use standard breathing machines. The company targets sleep specialists and ENT surgeons globally. Alphatec differentiates itself through an integrated ecosystem using subsidiaries like EOS imaging and SafeOp Surgical, serving primarily the US hospital market whilst expanding into Europe and Japan. Both companies operate in medical technology but represent different maturity levels and financial profiles for investors seeking healthcare device exposure.
Alphatec Holdings, a medical technology company specialising in spinal surgery solutions, reported strong first-quarter 2026 results with surgical revenue up 17% and total revenue growing 14% to $192 million. The company achieved non-GAAP adjusted EBITDA of $21 million whilst securing a new bank facility that reduces annual interest expenses by over $6 million. Growth was driven by a 21% increase in surgical case volume and 23% rise in net new surgeon users. The company reported an ending cash balance of $140 million and trailing twelve-month free cash flow of $7 million. For full-year 2026, Alphatec expects total revenue of approximately $882 million, representing 15% growth, with adjusted EBITDA projected at $134 million and at least $20 million in free cash flow generation.
Kirby McInerney LLP is investigating potential securities law violations by Alphatec Holdings and its senior management following a sharp share price decline. On 5 May 2026, Alphatec reported first quarter revenue of $192 million and disclosed that EOS revenue, from its proprietary imaging platform, was $14 million—below internal expectations. The company reduced its full-year 2026 EOS revenue guidance to approximately $77 million from $85 million, citing execution issues with equipment installations. Management stated that "installation timing was a challenge" and the company failed to fulfill committed units. Following the announcement, Alphatec shares fell 32%, from $10.23 to $6.99 per share. No lawsuit has been filed yet, and the investigation is ongoing to determine whether claims may be brought under federal securities laws.
Alphatec Holdings shares fell 25% to $6.99 following its first-quarter results, which showed revenue of $192 million, falling 2.3% short of analyst estimates. Statutory losses of $0.22 per share were 12% smaller than expected. Following the results, eleven analysts revised their forecasts, maintaining revenue expectations of $881.8 million for 2026, representing 12% growth. They improved loss predictions to $0.52 per share, down from $0.55 previously. However, the average price target fell 26% to $18.00, with individual targets ranging from $11.00 to $25.00. Analysts expect Alphatec Holdings' revenue growth to slow to 16% annually through 2026, down from 28% over the past five years, though this remains above the industry average of 8%.